BRCA1 and hypoparathyroidism-retardation-dysmorphism syndrome: Taken together, we deduced that BRCA1 mutation mediated homologous recombination deficiency (HRD), thus promoting the activation of the TNFα pathway via modulating the JUN and FOS expression, and ultimately induces the iCAF phenotype.